AI-generated summary
This is a perspective article that puts forward a hypothesis rather than reporting new experimental results. The authors propose that photobiomodulation, a light-based therapy, might reverse or slow age-related shrinkage of the thymus, possibly through melatonin synthesis or stimulation of bone marrow stem cells. The abstract presents this as a hypothesis that requires further testing.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a hypothesis-driven perspective with no reported experimental data, so the proposed mechanisms and effects remain untested.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Near-infrared, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.